- Home
- OVID vs NSPR Comparison
OVID vs NSPR Comparison
Compare OVID & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- NSPR
- Stock Information
- Founded
- OVID 2014
- NSPR 2005
- Country
- OVID United States
- NSPR United States
- Employees
- OVID N/A
- NSPR N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- NSPR Medical/Dental Instruments
- Sector
- OVID Health Care
- NSPR Health Care
- Exchange
- OVID Nasdaq
- NSPR Nasdaq
- Market Cap
- OVID 117.3M
- NSPR 99.7M
- IPO Year
- OVID 2017
- NSPR N/A
- Fundamental
- Price
- OVID $1.32
- NSPR $1.81
- Analyst Decision
- OVID Strong Buy
- NSPR Strong Buy
- Analyst Count
- OVID 4
- NSPR 2
- Target Price
- OVID $3.13
- NSPR $4.50
- AVG Volume (30 Days)
- OVID 1.7M
- NSPR 119.5K
- Earning Date
- OVID 11-13-2025
- NSPR 11-04-2025
- Dividend Yield
- OVID N/A
- NSPR N/A
- EPS Growth
- OVID N/A
- NSPR N/A
- EPS
- OVID N/A
- NSPR N/A
- Revenue
- OVID $6,651,000.00
- NSPR $7,779,000.00
- Revenue This Year
- OVID $1,081.80
- NSPR $7.48
- Revenue Next Year
- OVID N/A
- NSPR $104.39
- P/E Ratio
- OVID N/A
- NSPR N/A
- Revenue Growth
- OVID 1070.95
- NSPR 14.04
- 52 Week Low
- OVID $0.24
- NSPR $1.77
- 52 Week High
- OVID $2.01
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- OVID 41.52
- NSPR 22.72
- Support Level
- OVID $1.27
- NSPR $2.05
- Resistance Level
- OVID $1.44
- NSPR $2.40
- Average True Range (ATR)
- OVID 0.10
- NSPR 0.15
- MACD
- OVID -0.04
- NSPR -0.03
- Stochastic Oscillator
- OVID 14.29
- NSPR 29.05
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.